Annual Report 2025

REPORT OF THE DIRECTORS 33 The United Laboratories International Holdings Limited Annual Report 2025 During the year ended 31 December 2025, the movements of unvested Awarded Shares granted under the Share Award Scheme are as follows: Number of unvested Awarded Shares Grantee name/categories Date of grant Vesting period As at 1 Jan 2025 Granted during the year Vested during the year Lapsed during the year Cancelled during the year As at 31 December 2025 Directors of the Company: Tsoi Hoi Shan 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 383,400 – 191,700 – – 191,700 Leung Wing Hon 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 267,400 – 133,700 – – 133,700 Choy Siu Chit 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 179,200 – 89,600 – – 89,600 Fang Yu Ping 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 124,600 – 62,300 – – 62,300 Zou Xian Hong 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 124,600 – 62,300 – – 62,300 Zhu Su Yan 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 124,600 – 62,300 – – 62,300 Other employees of the Group: 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 6,860,800 – 2,767,900 520,100 142,400 3,430,400 Total Awarded Shares granted: 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 8,064,600 – 3,369,800 520,100 142,400 4,032,300 Five highest paid individuals in aggregate (note 1) : 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 1,079,200 – 539,600 – – 539,600 Notes: 1. All of the five highest paid individuals of the Group are directors of the Company. 2. There is no purchase price to be paid by the grantees. The consideration for each grant of the Awarded Shares in nil. 3. The closing prices of the shares of the Company immediate before the date of the grant and on the date of the grant of the unvested Awarded Shares were HK$7.77 and HK$7.45 per share respectively. 4. The fair value of the unvested Awarded Shares granted on 13 November 2023 was HK$7.45 per share as at the date of grant. 5. The accounting standard and policy adopted are set out in note 3 to the consolidated financial statements in 2025 Annual Report.